Key result
Beta-arrestin2 deletion alters CB1 receptor localization and reduces THC efficacy in mouse brain membranes.
Why the study?
Beta-arrestins regulate GPCR internalization, G-protein coupling, and signaling but their role in cannabinoid CB1 receptor regulation in brain was not investigated in vivo.
Beta-arrestin2 regulates cannabinoid CB1 receptors in the brain, influencing their subcellular localization and the efficacy of specific agonists like THC.
Answers are grounded in this paper and cite their sources.
Should not yet alter cannabinoid use; leaves open beta-arrestin2 modulation of CB1 signaling for future human studies.
CONTEXT: Beta-arrestins are known to couple to some G-protein-coupled receptors (GPCRs) to regulate receptor internalization, G-protein coupling and signal transduction, but have not been investigated for most receptors, and for very few receptors in vivo. Previous studies have shown that beta-arrestin2 deletion enhances the efficacy of specific cannabinoid agonists. OBJECTIVE: The present study hypothesized that brain cannabinoid CB1 receptors are regulated by beta-arrestin2. METHODS: Beta-arrestin2+/+ and -/- mice were used. Western blotting was used to determine the relative levels of each beta-arrestin subtype in mouse brain. Receptor binding was measured to determine whether deletion of beta-arrestin2 influences agonist binding to brain CB1 receptors, or the subcellular localization of CB1 in brain membranes subjected to differential centrifugation. A variety of cannabinoid agonists from different chemical classes were investigated for their ability to activate G-proteins in the presence and absence of beta-arrestin2 in cerebellum, hippocampus and cortex. RESULTS: No differences were found in the density of beta-arrestin1 or cannabinoid CB1 receptors in several brains of beta-arrestin2+/+ versus -/- mice. Differences between genotypes were found in the proportion of high- and low-affinity agonist binding sites in brain areas that naturally express higher levels of beta-arrestin2. Cortex from beta-arrestin2-/- mice contained less CB1 in the P1 fraction and more CB1 in the P2 fraction compared to beta-arrestin2+/+. Of the agonists assayed for activity, only Δ(9)-tetrahydrocannabinol (THC) exhibited a difference between genotypes, in that it was less efficacious in beta-arrestin2-/- than +/+ mouse membranes. CONCLUSION: Beta-arrestin2 regulates cannabinoid CB1 receptors in brain.
No takes yet. Share an insight, caveat, or question.
Breivogel et al. (2013) studied this question. Beta-arrestin2 deletion vs. Beta-arrestin2+/+ mice was evaluated on Cannabinoid CB1 receptor coupling to G-proteins and subcellular localization. Beta-arrestin2 deletion altered the subcellular localization of CB1 receptors in the cortex and reduced the efficacy of THC to activate G-proteins in mouse brain membranes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: